Morgan Stanley Starts GW Pharma (GWPH) at Overweight on Cannabis Platform Potential
Tweet Send to a Friend
Morgan Stanley initiated coverage on GW Pharma (NASDAQ: GWPH) with an Overweight rating and a price target of $103.00. Analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE